These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 2419702

  • 1. Activators and inactivators of Ca++ channels: new perspectives.
    Spedding M.
    J Pharmacol; 1985; 16(4):319-43. PubMed ID: 2419702
    [Abstract] [Full Text] [Related]

  • 2. [Recent advances in the pharmacology of the calcium channel].
    Wang ZG, Yang W.
    Yao Xue Xue Bao; 1985 Mar; 20(3):235-40. PubMed ID: 2416189
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA, Sarmiento JG, Maurer SC, Bolger GT, Triggle DJ.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human red blood cells--an ideal model system for the action of calcium agonists and antagonists.
    Stimpel M, Neyses L, Locher R, Groth H, Vetter W.
    J Hypertens Suppl; 1984 Dec; 2(3):S577-80. PubMed ID: 6085891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
    Affolter H, Coronado R.
    Biophys J; 1985 Aug; 48(2):341-7. PubMed ID: 2413915
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
    Kozlowski R, Ehrhard P, Fischli W, Osterrieder W, Holck M.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Action of organic antagonists on neuronal calcium currents.
    Boll W, Lux HD.
    Neurosci Lett; 1985 May 23; 56(3):335-9. PubMed ID: 2410819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dihydropyridine Ca2+ agonists and channel blockers interact in the opposite manner with photogenerated unpaired electrons.
    Marinov BS, Saxon ME.
    FEBS Lett; 1985 Jul 08; 186(2):251-4. PubMed ID: 2408923
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
    Young W, Chen J, Jung F, Gardner P.
    Mol Pharmacol; 1988 Sep 08; 34(3):239-44. PubMed ID: 2458520
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.